心泰医疗(02291)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02291 心泰医疗

未开盘 08-27 16:08:29

13.900

+0.000

0.00%

最高14.770	最低13.880	成交量68.60万
今开14.150	昨收13.900	日振幅6.40%
总市值48.23亿	流通市值48.20亿	总股本3.47亿
成交额978.80万	换手率0.20%	流通股本3.47亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02291","market":"HK","secType":"STK","nameCN":"心泰医疗","latestPrice":13.9,"timestamp":1787818109346,"preClose":13.9,"halted":0,"volume":686000,"delay":0,"changeRate":0,"floatShares":346749997,"shares":347000000,"eps":0.8048927264033362,"marketStatus":"未开盘","change":0,"latestTime":"08-27 16:08:29","open":14.15,"high":14.77,"low":13.88,"amount":9787970,"amplitude":0.064029,"askPrice":14.2,"askSize":40000,"bidPrice":13.9,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":0.685539966700896,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787880600000},"marketStatusCode":0,"adr":0,"listingDate":1667836800000,"exchange":"SEHK","adjPreClose":13.9,"dividendRate":0.041201,"openAndCloseTimeList":[[1787794200000,1787803200000],[1787806800000,1787817600000]],"volumeRatio":0.14920828258351496,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02291","defaultTab":"news","newsList":[{"id":"1150419087","title":"心泰医疗8月27日回购4.1万股，耗资约57.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150419087","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150419087?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:48","pubTimestamp":1787831285,"startTime":"0","endTime":"0","summary":"心泰医疗于2026年8月27日发布公告，披露公司当日在香港联交所场内回购股份共计41,000股，约占已发行股本的0.0118%。本次回购价格介于每股港币13.90元至14.15元之间，合计耗资港币579,161.90元。公司表示，上述股份目前尚未注销，截至当日收盘仍维持已发行股本346,749,997股，库藏股维持为0股。公司确认本次回购活动已严格遵守香港联交所证券上市规则及相关法律规定，下一次进行新股发行或再次出售、转让库藏股的暂止期截至2026年9月26日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"心泰医疗8月27日回购4.1万股，耗资约57.92万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662770415","title":"心泰医疗(02291.HK)8月27日斥资57.9万港元回购4.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662770415","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662770415?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:45","pubTimestamp":1787831142,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148000230","title":"心泰医疗回购3,000股股份，斥资约4.09万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148000230","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148000230?lang=zh_cn&edition=full","pubTime":"2026-08-26 18:42","pubTimestamp":1787740941,"startTime":"0","endTime":"0","summary":"2026年8月26日，心泰医疗发布翌日披露报表。公告显示，公司于当日在香港联交所场内回购3,000股H股普通股，每股回购价为13.62港元，合共涉及约4.09万港元，占该日现有已发行股本约0.0009%。本次回购完成后，公司已发行股本数维持在346,749,997股，未发生变化，且公司并无持有任何库存股份。根据公告，心泰医疗回购授权决议于2026年5月22日获通过，授权购回股份总数为34,674,999股。公司同时确认，已遵守上市规则及相关法律法规的规定。公告由联席公司秘书秦学签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心泰医疗回购3,000股股份，斥资约4.09万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662632731","title":"心泰医疗(02291)8月25日斥资55.73万港元回购4.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662632731","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662632731?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:41","pubTimestamp":1787658091,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心泰医疗(02291)发布公告，于2026年8月25日斥资55.73万港元回购4.2万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485286.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157696768","title":"心泰医疗：8月25日回购42,000股，涉资约55.73万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157696768","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157696768?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:36","pubTimestamp":1787657772,"startTime":"0","endTime":"0","summary":"乐普心泰医疗科技（上海）股份有限公司（股票代码：02291，股票名称：心泰医疗）于2026年8月25日发布翌日披露报表。公司当日按每股12.85港元至13.30港元的价格区间，于香港联交所场内回购股份42,000股，约占已发行股本的0.0121%，合计耗资约55.73万港元。此次回购完成后，公司已发行股本仍为346,749,997股，库藏股数量为0股。\n根据公告，心泰医疗于2026年5月22日获得购回授权，总额为34,674,999股。截至本次回购，公司已累计回购2,098,000股。公司确认此次回购已获得董事会正式批准，并遵守了香港联交所上市规则和相关法律法规。公告由联席公司秘书秦学签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心泰医疗：8月25日回购42,000股，涉资约55.73万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298297","title":"心泰医疗(02291.HK)拟10.88亿元收购上海民为生物技术54.2384%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298297","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661298297?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:49","pubTimestamp":1787316540,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161216897","title":"心泰医疗（02291）拟10.88亿元收购上海民为54.2384%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1161216897","media":"公告速递","labels":["shareholding","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161216897?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:32","pubTimestamp":1787315556,"startTime":"0","endTime":"0","summary":"心泰医疗8月21日公告称，公司已与控股股东乐普（北京）医疗器械股份有限公司及上海民为生物技术有限公司签订《股份转让协议》，拟以现金人民币10.88亿元收购上海民为54.2384%股权。交易完成后，上海民为将成为心泰医疗的非全资附属公司，其财务业绩、资产及负债将并表纳入公司报表。本次交易款项分两期支付：一是交割条件达成或获豁免后支付首期价款人民币6.53亿元；二是在上海民为完成工商变更登记之日起18个月内支付剩余4.35亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160417739","title":"心泰医疗拟斥资10.9亿元人民币收购上海闵微生物科技54.2384%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1160417739","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160417739?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:27","pubTimestamp":1787315228,"startTime":"0","endTime":"0","summary":"心泰医疗（SCIENTECH）宣布，计划以人民币10.9亿元收购上海闵微生物科技54.2384%的股权。此举标志着心泰医疗在生物科技领域的战略布局进一步深化，旨在通过整合资源与技术，增强其在医疗器械及相关领域的核心竞争力。交易完成后，心泰医疗将成为上海闵微生物科技的控股股东，有望在研发、生产及市场拓展等方面实现协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260000","title":"心泰医疗(02291)发布中期业绩，归母净利润1.47亿元 同比减少19.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260000","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661260000?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:14","pubTimestamp":1787314450,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心泰医疗 发布截至2026年6月30日止6个月中期业绩，该集团取得营业总收入3.1亿元，同比减少5.94%;归属于母公司股东的净利润1.47亿元，同比减少19.49%;基本每股收益0.4226元。本集团已搭建起先天性心脏病、电生理、瓣膜及国际贸易四个专业营销团队，持续拓展销售渠道，通过集采落地推动国内各管线产品加速市场渗透。在国内市场各管线加速渗透的同时，本集团亦同步加快海外业务的战略布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180411421","title":"心泰医疗（02291）2026年中期业绩：收入3.10亿元同比降5.9%，可降解PFO封堵器带动心源性卒中预防产品收入大增","url":"https://stock-news.laohu8.com/highlight/detail?id=1180411421","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180411421?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:56","pubTimestamp":1787313372,"startTime":"0","endTime":"0","summary":"8月21日，心泰医疗科技（上海）股份有限公司公布2026年中期业绩。报告期内，公司实现营业收入3.101亿元，同比下降5.9%；归属母公司股东净利润1.465亿元，同比减少19.5%。公司董事会不建议派发中期股息。报告期经营活动净现金流1.468亿元，投资活动净流出4,910万元；期末现金及现金等价物余额12.338亿元。报告期末，公司拥有32款已上市产品，3款处于注册阶段，27款在研。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124830345","title":"心泰医疗中期业绩：归母净利润达人民币1.82亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124830345","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124830345?lang=zh_cn&edition=full","pubTime":"2026-08-21 19:52","pubTimestamp":1787313129,"startTime":"0","endTime":"0","summary":"心泰医疗（股票代码：02291）近日披露了截至上半年的财务报告，数据显示公司归属于母公司股东的净利润达到了人民币1.82亿元。这一成绩反映了公司在医疗科技领域的持续稳健发展。市场分析人士指出，这一业绩表现或将为公司未来的战略布局提供更为坚实的财务基础。值得关注的是，心泰医疗在心血管介入器械领域的市场份额及产品创新能力，一直是投资者关注的焦点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661926292","title":"乐普医疗最新公告：拟10.88亿元向心泰医疗转让上海民为生物54.2384%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2661926292","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661926292?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:50","pubTimestamp":1787309446,"startTime":"0","endTime":"0","summary":"乐普医疗(300003.SZ)公告称，公司将持有的上海民为生物54.2384%股权转让给控股子公司心泰医疗，转让价款10.88亿元。本次交易属于公司内部股权转让，不涉及合并报表范围变化。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100035378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003","BK0188","BK0113","BK0196","BK0114","BK0201","BK0251","BK0042","BK1100","BK0028","02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991648","title":"心泰医疗(02291.HK)拟8月21日举行董事会会议以审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991648","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658991648?lang=zh_cn&edition=full","pubTime":"2026-08-11 18:17","pubTimestamp":1786443423,"startTime":"0","endTime":"0","summary":"格隆汇8月11日丨心泰医疗(02291.HK)公告，公司将于2026年8月21日(星期五)举行董事会会议，藉以(其中包括)考虑及批准公司及其附属公司截至2026年6月30日止6个月的未经审核中期业绩及其发布，并考虑建议派发中期股息(如有)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260811/32331848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02291","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198571274","title":"心泰医疗将于2026年8月21日审议中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1198571274","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198571274?lang=zh_cn&edition=full","pubTime":"2026-08-11 18:01","pubTimestamp":1786442460,"startTime":"0","endTime":"0","summary":"乐普心泰医疗科技（上海）股份有限公司（股票代码：02291）8月11日公告称，公司董事会已排期于2026年8月21日（星期五）召开会议，审议并批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩，并同步考虑建议派发中期股息（如有）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199398301","title":"心泰医疗7月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1199398301","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199398301?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:48","pubTimestamp":1786009716,"startTime":"0","endTime":"0","summary":"心泰医疗于2026年8月6日发布截至2026年7月31日止的证券变动月报表。公告显示，公司注册股本在报告期内无变化，维持人民币346,749,997元不变。根据报告，心泰医疗于本月末已发行普通股H股总数与上个月保持一致，数量为346,749,997股，库存股份数为0股，公示当月无新增发行或股本注销行为。该月报表由心泰医疗联席公司秘书秦学签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653737523","title":"港股异动 | 心泰医疗(02291.HK)尾盘涨超14% MemoSorb ASD/VSD封堵器获沙特阿拉伯上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2653737523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653737523?lang=zh_cn&edition=full","pubTime":"2026-07-22 15:21","pubTimestamp":1784704877,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104987412","title":"心泰医疗：7月21日回购36,000股，耗资约41.09万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104987412","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104987412?lang=zh_cn&edition=full","pubTime":"2026-07-21 18:30","pubTimestamp":1784629859,"startTime":"0","endTime":"0","summary":"心泰医疗于2026年7月21日公布翌日披露报表。公告显示，公司于同日于香港联交所场内回购36,000股H股股份，占相关事件前已发行股份约0.0104%，每股回购价格介乎港币11.32元至11.44元，合计耗资410,929.20港元，折合约41.09万港元。完成本次回购后，公司已发行股份总数仍为346,749,997股，库藏股份维持为0股。截至7月21日，公司在香港联交所或其他证券交易所合计购回的股份数量为2,056,000股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心泰医疗：7月21日回购36,000股，耗资约41.09万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140700425","title":"心泰医疗7月20日回购81,000股，耗资约90.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1140700425","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140700425?lang=zh_cn&edition=full","pubTime":"2026-07-20 18:30","pubTimestamp":1784543452,"startTime":"0","endTime":"0","summary":"2026年7月20日，心泰医疗发布翌日披露报表。公告显示，公司于当日于香港联交所回购H股普通股81,000股，占该公司根据上一交易日已发行股本约0.0234%，回购价格介乎每股港币11.16元至港币11.23元，总耗资约港币90.92万元。据悉，公司已于2026年5月22日通过购回授权，获准可回购股份总数为34,674,999股，截至目前已合计回购2,020,000股，约占购回授权通过当日已发行股本的0.5826%。上述公告由心泰医疗联席公司秘书秦学签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心泰医疗7月20日回购81,000股，耗资约90.92万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652292194","title":"心泰医疗(02291)7月20日耗资约90.92万港元回购8.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652292194","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652292194?lang=zh_cn&edition=full","pubTime":"2026-07-20 18:28","pubTimestamp":1784543315,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心泰医疗(02291)公布，2026年7月20日耗资约90.92万港元回购8.1万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02291"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652407335","title":"心泰医疗(02291)7月17日斥资43.93万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652407335","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652407335?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:47","pubTimestamp":1784285239,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心泰医疗(02291)发布公告，于2026年7月17日斥资43.93万港元回购4万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02291"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientechmed.com","stockEarnings":[{"period":"1week","weight":0.1412},{"period":"1month","weight":0.0139},{"period":"3month","weight":0.4464},{"period":"6month","weight":-0.0816},{"period":"1year","weight":-0.3585},{"period":"ytd","weight":-0.0896}],"compareEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":0.0101},{"period":"3month","weight":0.0152},{"period":"6month","weight":-0.04},{"period":"1year","weight":0.0144},{"period":"ytd","weight":-0.0025}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"乐普心泰医疗科技（上海）股份有限公司是一家主要从事针对结构性心脏病的介入医疗器械的研发、制造及商业化的中国公司。该公司主要通过两个部门开展业务。封堵器业务部门主要从事缺损性先天性心脏病介入治疗系列封堵器的研发及销售业务。心脏瓣膜业务部门主要从事心脏瓣膜医疗器械的研发业务。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.013111},{"month":2,"riseRate":0.75,"avgChangeRate":0.025991},{"month":3,"riseRate":0,"avgChangeRate":-0.085053},{"month":4,"riseRate":0.25,"avgChangeRate":0.025586},{"month":5,"riseRate":0.5,"avgChangeRate":-0.084766},{"month":6,"riseRate":0.5,"avgChangeRate":0.033926},{"month":7,"riseRate":0.75,"avgChangeRate":0.103736},{"month":8,"riseRate":0.25,"avgChangeRate":-0.022179},{"month":9,"riseRate":0.666667,"avgChangeRate":0.017088},{"month":10,"riseRate":0,"avgChangeRate":-0.044764},{"month":11,"riseRate":0.333333,"avgChangeRate":0.003892},{"month":12,"riseRate":0.25,"avgChangeRate":-0.039294}],"exchange":"SEHK","name":"心泰医疗","nameEN":"SCIENTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心泰医疗(02291)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心泰医疗(02291)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心泰医疗,02291,心泰医疗股票,心泰医疗股票老虎,心泰医疗股票老虎国际,心泰医疗行情,心泰医疗股票行情,心泰医疗股价,心泰医疗股市,心泰医疗股票价格,心泰医疗股票交易,心泰医疗股票购买,心泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心泰医疗(02291)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心泰医疗(02291)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}